Want to join the conversation?
Charlotte, North Carolina-based $DUK posted 1Q16 net income attributable to the company of $694MM or $1.01 per diluted share versus $864MM or $1.22 per diluted share in 1Q15. Total operating revenue was $5.62Bil compared to $6.07Bil last year. 1Q16 adjusted diluted EPS was $1.13 compared to $1.24 in 1Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?